Press Releases from Themis Bioscience (5 total)
NIH and Themis Bioscience Announce the Initiation of a Clinical Trial of a Chiku …
A prophylactic vaccine candidate against Chikungunya fever developed with proprietary technology of Themis Bioscience GmbH will be tested in a clinical trial sponsored by the…
Zika Virus: Top EU-Groups Join Forces in Quest for Vaccine
Themis Measles Vector Technology Central to Action Plan
Leading European research groups pool their expertise for the fast development of an effective and affordable vaccine against…
Zika Virus: Top EU-Groups Join Forces in Quest for Vaccine
Themis Measles Vector Technology Central to Action Plan
Vienna, 13 December 2016 – Leading European research groups pool their expertise for the fast development of an…
Zika-Vaccine Receives Boost by Innovate UK
The further development of a promising Zika vaccine candidate by Themis Bioscience has received a strong support by the United Kingdom's innovation agency, Innovate UK.…
Leading Chikungunya Vaccine in Clinical Trial Phase 2
With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is…
Go To Page:
